An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.
about
Spinal Cord as an Adjunct to Brain Magnetic Resonance Imaging in Defining "No Evidence of Disease Activity" in Multiple Sclerosis.T1- vs. T2-based MRI measures of spinal cord volume in healthy subjects and patients with multiple sclerosis.Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosisBrain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosisNovel composite MRI scale correlates highly with disability in multiple sclerosis patients.An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis.The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis.The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis.The Effect of Glatiramer Acetate on Spinal Cord Volume in Relapsing-Remitting Multiple Sclerosis.The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis.Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.
P2860
Q33769234-85539E6F-021C-48EC-81A2-23AED2528A97Q35728137-07DB90F9-2CFF-4E87-BCDC-3ADBE641716FQ35997017-E1DA763D-FD8B-45F2-9326-0E4DE3A1EE75Q36156669-682D101E-8CC9-4FAE-A860-3671393026D4Q36265339-040ADE5A-1C0F-4292-A837-1CA9433CF791Q36307718-F381AA44-0A1C-4FD8-A192-3CB72A5DD6D3Q36670128-271C5AD4-51B9-41D0-8EE0-0044629E66B5Q37048758-2B4097DF-AFCA-4A6F-A3FD-4D5D83E270DDQ37459099-46F73C81-5F27-4302-A617-5A9931B23D70Q37596025-831A873D-1800-4A8C-9A0D-6A90D17D28D6Q41475478-27CB4716-AA0E-453B-BB67-B4894EBA7C56Q47242221-601E148B-1026-4FB9-A71C-F0C691A02F3AQ48343851-93BFD707-0337-4235-93CD-4F6D07051039
P2860
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
An expanded composite scale of ...... in multiple sclerosis: MRDSS2.
@ast
An expanded composite scale of ...... in multiple sclerosis: MRDSS2.
@en
An expanded composite scale of ...... in multiple sclerosis: MRDSS2.
@nl
type
label
An expanded composite scale of ...... in multiple sclerosis: MRDSS2.
@ast
An expanded composite scale of ...... in multiple sclerosis: MRDSS2.
@en
An expanded composite scale of ...... in multiple sclerosis: MRDSS2.
@nl
prefLabel
An expanded composite scale of ...... in multiple sclerosis: MRDSS2.
@ast
An expanded composite scale of ...... in multiple sclerosis: MRDSS2.
@en
An expanded composite scale of ...... in multiple sclerosis: MRDSS2.
@nl
P2093
P2860
P1433
P1476
An expanded composite scale of ...... in multiple sclerosis: MRDSS2.
@en
P2093
Antonia Ceccarelli
Bonnie I Glanz
Brian C Healy
Charles R G Guttmann
Christopher Severson
Gloria Kim
James M Stankiewicz
Jennifer Miller
Julia L Berkowitz
Lynn Stazzone
P2860
P304
P356
10.1097/WNR.0000000000000244
P577
2014-10-01T00:00:00Z